CLINICAL_TRIALS
trial_result
· 2021-05-14
Clinical Trial Update: New Formulations of Propafenone to Treat Atrial Fibrillation [Phase 1, Phase 2]
Summary
Phase 1/2 trial update on new formulations of propafenone for atrial fibrillation; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt University | Conditions: Atrial Fibrillation | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-05-14